IgA receptors in health and disease

Tissue Antigens

Volumn 68, Issue 2, 2006, Pages 103-114

  Wines, Bruce D ^a   Hogarth, P Mark ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Antibodies; Fc receptor; IgA; IgA nephropathy; Mucosal immunity; Secretory IgA

Indexed keywords

FC RECEPTOR; GALECTIN 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN RECEPTOR; SECRETORY COMPONENT; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; IGA RECEPTOR; IGA, SECRETORY RECEPTOR; IMMUNOGLOBULIN J CHAIN; LEUKOCYTE ANTIGEN; SECRETORY IMMUNOGLOBULIN;

ANTIGEN PRESENTATION; ASTHMA; AUTOIMMUNE DISEASE; CELL TRANSPORT; DEGRANULATION; DENDRITIC CELL; ENTERITIS; EOSINOPHIL; EPITHELIUM CELL; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; MACROPHAGE; MONOCYTE; MUCOSA; MUCOSA CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RESPIRATORY BURST; REVIEW; T LYMPHOCYTE; ANIMAL; BONE MARROW CELL; CHEMISTRY; IMMUNITY; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; MESANGIUM CELL; METABOLISM; MUCOSAL IMMUNITY; PROTEIN TRANSPORT;

ANIMALS; ANTIGENS, CD; EOSINOPHILS; HUMANS; IMMUNITY; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN J-CHAINS; INFLAMMATION; LYMPHOCYTES; MESANGIAL CELLS; MYELOID CELLS; PROTEIN TRANSPORT; RECEPTORS, FC;

EID: 33747195313     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00613.x     Document Type: Review

References (83)

1. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006: 208: 270-82.
2. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005: 206: 32-63.
3. Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 1999: 19: 481-508.
4. Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 2005: 206: 83-99.
5. Braathen R, Sorensen V, Brandtzaeg P, Sandlie I, Johansen FE. The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor. J Biol Chem 2002: 277: 42755-62.
6. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001: 292: 1115-8.
7. Schneeman TA, Bruno ME, Schjerven H, Johansen FE, Chady L, Kaetzel CS. Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses. J Immunol 2005: 175: 376-84.
8. Hamburger AE, West AP, Bjorkman PJ. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure 2004: 12: 1925-35.
9. Bakos MA, Kurosky A, Goldblum RM. Characterization of a critical binding site for human polymeric Ig on secretory component. J Immunol 1991: 147: 3419-26.
10. Coyne RS, Siebrecht M, Peitsch MC, Casanova JE. Mutational analysis of polymeric immunoglobulin receptor/ ligand interactions. Evidence for the involvement of multiple complementarity determining region (CDR)-like loops in receptor domain I. J Biol Chem 1994: 269: 31620-5.
11. Shibuya A, Sakamoto N, Shimizu Y et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000: 1: 441-6.
12. Norderhaug IN, Johansen FE, Krajci P, Brandtzaeg P. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction. Eur J Immunol 1999: 29: 3401-9.
13. Chintalacharuvu KR, Tavill AS, Louis LN, Vaerman JP, Lamm ME, Kaetzel CS. Disulfide bond formation between dimeric immunoglobulin A and the polymeric immunoglobulin receptor during hepatic transcytosis. Hepatology 1994: 19: 162-73.
14. Vaerman JP, Langendries AE, Giffroy DA et al. Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA. Eur J Immunol 1998: 28: 171-82.
15. Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol 2000: 52: 240-8.
16. Johansen FE, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001: 167: 5185-92.
17. Hexham JM, White KD, Carayannopoulos LN et al. A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretion. J Exp Med 1999: 189: 747-52.
18. Lewis MJ, Pleass RJ, Batten MR, Atkin JD, Woof JM. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J Immunol 2005: 175: 6694-701.
19. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002: 17: 107-15.
20. Johansen FE, Pekna M, Norderhaug IN et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 1999: 190: 915-22.
21. Sun K, Johansen FE, Eckmann L, Metzger DW. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J Immunol 2004: 173: 4576-81.
22. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med 2006: 203: 21-6.
23. Braathen R, Sandvik A, Berntzen G et al. Identification of a polymeric Ig receptor-binding phage-displayed peptide that exploits epithelial transcytosis without dimeric IgA competition. J Biol Chem 2006: 281: 7075-81.
24. McDonald KJ, Cameron AJ, Allen JM, Jardine AG. Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 2002: 290: 438-42.
25. Sakamoto N, Shibuya K, Shimizu Y et al. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 2001: 31: 1310-6.
26. Moura IC, Centelles MN, Arcos-Fajardo M et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001: 194: 417-25.
27. Moura IC, Lepelletier Y, Arnulf B et al. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 2004: 103: 1838-45.
28. Otten MA, van Egmond M. The Fc receptor for IgA (FcalphaRI, CD89). Immunol Lett 2004: 92: 23-31.
29. Morton HC. IgA Fc receptors in cattle and horses. Vet Immunol Immunopathol 2005: 108: 139-43.
30. Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol 2003: 21: 177-204.
31. Maruoka T, Nagata T, Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics 2004: 55: 712-6.
32. Bracke M, Lammers JW, Coffer PJ, Koenderman L. Cytokine-induced inside-out activation of FcalphaR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood 2001: 97: 3478-83.
33. Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. J Immunol 1999: 162: 2146-53.
34. Morton HC, Brandtzaeg P. CD89: the human myeloid IgA Fc receptor. Arch Immunol Ther Exp (Warsz) 2001: 49: 217-29.
35. Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 2001: 166: 1781-9.
36. Herr AB, Ballister ER, Bjorkman PJ. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 2003: 423: 614-20.
37. Weisbart RH, Kacena A, Schuh A, Golde DW. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988: 332: 647-8.
38. van Egmond M, van Garderen E, van Spriel AB et al. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000: 6: 680-5.
39. Wines BD, Willoughby N, Fraser JD, Hogarth PM. A competitive mechanism for staphylococcal toxin SSL7 Inhibiting the Leukocyte IgA Receptor, Fc{alpha}RI, is revealed by SSL7 binding at the C{alpha}2/C{alpha}3 interface of IgA. J Biol Chem 2006: 281: 1389-93.
40. Launay P, Grossetete B, Arcos-Fajardo M et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000: 191: 1999-2009.
41. Otten MA, Rudolph E, Dechant M et al. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol 2005: 174: 5472-80.
42. Pasquier B, Launay P, Kanamaru Y et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005: 22: 31-42.
43. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989: 142: 2393-400.
44. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998: 161: 4340-6.
45. Motegi Y, Kita H, Kato M, Morikawa A. Role of secretory IgA, secretory component, and eosinophils in mucosal inflammation. Int Arch Allergy Immunol 2000: 122: 25-7.
46. Decot V, Woerly G, Loyens M et al. Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils. J Immunol 2005: 174: 628-35.
47. Kaneko M, Horie S, Kato M, Gleich GJ, Kita H. A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1995: 155: 2631-41.
48. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994: 152: 5457-67.
49. Van Spriel AB, Leusen JH, Vile H, Van De Winkel JG. Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA. J Immunol 2002: 169: 3831-6.
50. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995: 25: 117-25.
51. Bartemes KR, Cooper KM, Drain KL, Kita H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005: 116: 827-35.
52. Iikura M, Yamaguchi M, Miyamasu M et al. Secretory IgA-mediated basophil activation. II. Roles of GTP-binding regulatory proteins and phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 1999: 264: 575-9.
53. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig) A1 and IgA2 isotypes. J Exp Med 2000: 191: 2171-82.
54. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998: 9: 2048-54.
55. Moura IC, Arcos-Fajardo M, Gdoura A et al. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005: 16: 2667-76.
56. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004: 15: 622-34.
57. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 2004: 36: 2137-43.
58. Sangeetha SR, Appukuttan PS. IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1→3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand. Int J Biol Macromol 2005: 35: 269-76.
59. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001: 2: 1004-9.
60. Man AL, Prieto-Garcia ME, Nicoletti C. Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys? Immunology 2004: 113: 15-22.
61. Niedergang F, Kraehenbuhl JP. Much ado about M cells. Trends Cell Biol 2000: 10: 137-41.
62. Hamzaoui N, Kerneis S, Caliot E, Pringault E. Expression and distribution of beta1 integrins in in vitro-induced M cells: implications for Yersinia adhesion to Peyer's patch epithelium. Cell Microbiol 2004: 6: 817-28.
63. Schulte R, Kerneis S, Klinke S et al. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol 2000: 2: 173-85.
64. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997: 277: 949-52.
65. Marchetti M, Sirard JC, Sansonetti P, Pringault E, Kerneis S. Interaction of pathogenic bacteria with rabbit appendix M cells: bacterial motility is a key feature in vivo. Microbes Infect 2004: 6: 521-8.
66. Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 2002: 99: 9410-4.
67. Jang MH, Kweon MN, Iwatani K et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004: 101: 6110-5.
68. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000: 288: 2222-6.
69. Mach J, Hshieh T, Hsieh D, Grubbs N, Chervonsky A. Development of intestinal M cells. Immunol Rev 2005: 206: 177-89.
70. Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol 2004: 172: 3026-33.
71. Roy MJ, Varvayanis M. Development of dome epithelium in gut-associated lymphoid tissues: association of Iga with M cells. Cell Tissue Res 1987: 248: 645-51.
72. Mantis NJ, Cheung MC, Chintalacharuvu KR, Rey J, Corthesy B, Neutra MR. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol 2002: 169: 1844-51.
73. Corthesy B, Kaufmann M, Phalipon A, Peitsch M, Neutra MR, Kraehenbuhl JP. A pathogen-specific epitope inserted into recombinant secretory immunoglobulin A is immunogenic by the oral route. J Biol Chem 1996: 271: 33670-7.
74. Favre L, Spertini F, Corthesy B. Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol 2005: 175: 2793-800.
75. Kitamura T, Garofalo RP, Kamijo A et al. Human intestinal epithelial cells express a novel receptor for IgA. J Immunol 2000: 164: 5029-34.
76. Mota G, Manciulea M, Cosma E et al. Human NK cells express Fc receptors for IgA which mediate signal transduction and target cell killing. Eur J Immunol 2003: 33: 2197-205.
77. Phillips-Quagliata JM, Patel S, Han JK et al. The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor. J Immunol 2000: 165: 2544-55.
78. Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. Immunology 1994: 83: 99-106.
79. Swenson CD, Patel T, Parekh RB et al. Human T cell IgD receptors react with O-glycans on both human IgD and IgA1. Eur J Immunol 1998: 28: 2366-72.
80. Sun Z, Almogren A, Furtado PB, Chowdhury B, Kerr MA, Perkins SJ. Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. J Mol Biol 2005: 353: 155-73.
81. Swenson CD, Rizinashvili E, Amin AR, Thorbecke GJ. Oligomeric IgD augments and monomeric IgD inhibits the generation of IgG memory antibody responses in normal, but not in IgD-deficient, mice. J Immunol 1995: 154: 653-63.
82. Aicher WK, McGhee ML, McGhee JR et al. Properties of IgA-binding receptors on murine T cells: relative importance of Fc alpha R, beta-galactosyltransferase and anti-secretory component reactive proteins (ASCP). Scand J Immunol 1992: 35: 469-86.
83. Jump RL, Levine AD. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J Immunol 2002: 168: 6113-9.